JP2015500387A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500387A5
JP2015500387A5 JP2014547145A JP2014547145A JP2015500387A5 JP 2015500387 A5 JP2015500387 A5 JP 2015500387A5 JP 2014547145 A JP2014547145 A JP 2014547145A JP 2014547145 A JP2014547145 A JP 2014547145A JP 2015500387 A5 JP2015500387 A5 JP 2015500387A5
Authority
JP
Japan
Prior art keywords
chemically modified
kda
molecular weight
modified heparin
heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014547145A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015500387A (ja
JP6703806B2 (ja
Filing date
Publication date
Priority claimed from PCT/SE2011/051538 external-priority patent/WO2013095215A1/en
Application filed filed Critical
Publication of JP2015500387A publication Critical patent/JP2015500387A/ja
Publication of JP2015500387A5 publication Critical patent/JP2015500387A5/ja
Application granted granted Critical
Publication of JP6703806B2 publication Critical patent/JP6703806B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2014547145A 2011-12-19 2012-12-19 低抗凝固剤ヘパリン Active JP6703806B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SEPCT/SE2011/051538 2011-12-19
PCT/SE2011/051538 WO2013095215A1 (en) 2011-12-19 2011-12-19 Low anticoagulant heparins
PCT/SE2012/051428 WO2013095276A1 (en) 2011-12-19 2012-12-19 Low anticoagulant heparins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018112162A Division JP2018154848A (ja) 2011-12-19 2018-06-12 低抗凝固剤ヘパリン

Publications (3)

Publication Number Publication Date
JP2015500387A JP2015500387A (ja) 2015-01-05
JP2015500387A5 true JP2015500387A5 (https=) 2016-12-01
JP6703806B2 JP6703806B2 (ja) 2020-06-03

Family

ID=48668926

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014547145A Active JP6703806B2 (ja) 2011-12-19 2012-12-19 低抗凝固剤ヘパリン
JP2018112162A Pending JP2018154848A (ja) 2011-12-19 2018-06-12 低抗凝固剤ヘパリン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018112162A Pending JP2018154848A (ja) 2011-12-19 2018-06-12 低抗凝固剤ヘパリン

Country Status (26)

Country Link
US (2) US9480702B2 (https=)
EP (2) EP2794667B1 (https=)
JP (2) JP6703806B2 (https=)
CN (1) CN104053675B (https=)
AU (1) AU2012354226B2 (https=)
BR (1) BR112014014673B1 (https=)
CA (2) CA2856477C (https=)
CY (2) CY1120197T1 (https=)
DK (2) DK2794667T3 (https=)
ES (2) ES2669055T3 (https=)
HR (2) HRP20180725T1 (https=)
HU (2) HUE037554T2 (https=)
IL (1) IL232903A (https=)
IN (1) IN2014MN01056A (https=)
MX (1) MX358439B (https=)
MY (1) MY170069A (https=)
NO (2) NO2794667T3 (https=)
PH (1) PH12014501387A1 (https=)
PL (2) PL2794666T3 (https=)
PT (2) PT2794666T (https=)
RS (2) RS57214B1 (https=)
SI (2) SI2794666T1 (https=)
SM (2) SMT201800217T1 (https=)
TN (2) TN2014000237A1 (https=)
WO (3) WO2013095215A1 (https=)
ZA (1) ZA201403654B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
CN104144950B (zh) 2011-12-19 2017-09-05 迪乐方有限责任公司 含有重复的二糖单元的非抗凝的葡糖胺聚糖及其医药用途
GB2515315A (en) 2013-06-19 2014-12-24 Dilafor Ab New Processes
ES2749076T3 (es) * 2014-04-30 2020-03-19 Inst Nat Sante Rech Med DNasa para uso en el tratamiento de crisis vaso-oclusivas
EP2965764A1 (en) * 2014-07-11 2016-01-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for treating vaso-occlusive crisis
CN105504097B (zh) * 2015-12-30 2018-07-03 深圳市海普瑞药业集团股份有限公司 一种硫酸化肝素寡糖及其制备方法和应用
CN108424474B (zh) * 2017-02-15 2023-07-25 清华大学 去抗凝肝素衍生物及其用于炎症性肠病的治疗
CA3097047A1 (en) * 2018-04-13 2019-10-17 University Of Virginia Patent Foundation Compositions and methods for preparing and using non-immunogenic fast annealing microporous annealed particle hydrogels
CN109481692A (zh) * 2018-11-30 2019-03-19 东南大学 一种青蒿琥酯肝素衍生物及其药物组合物和应用
US20250205392A1 (en) * 2022-03-29 2025-06-26 The Penn State Research Foundation Device and method for accelerating and guiding vascularization
WO2023215594A1 (en) 2022-05-05 2023-11-09 Venture Health Studio, Llc Magnetic power distribution assembly
KR20250019674A (ko) * 2022-06-06 2025-02-10 아이에이치피 테라퓨틱스 인크. 화학적으로 변형된 헤파린
JP2025519467A (ja) * 2022-06-06 2025-06-26 アイエイチピー セラピューティクス インコーポレイテッド 化学的に修飾されたヘパリン
CN115448994B (zh) * 2022-09-28 2023-08-01 山东大学 一种可中和抗凝低分子量肝素及其制备方法和应用
US12059430B2 (en) 2022-09-29 2024-08-13 Adora Animal Health Corporation Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions
GB2625581A (en) * 2022-12-21 2024-06-26 Modus Therapeutics Ab New medical use
EP4665360A1 (en) 2023-02-17 2025-12-24 Modus Therapeutics AB New medical use of sevuparin in the treatment of endotoxemia
GB2627263A (en) * 2023-02-17 2024-08-21 Modus Therapeutics Ab New medical use
CN116854838A (zh) * 2023-06-30 2023-10-10 重庆望业药物研究有限公司 低分子多糖及其制备方法与应用
GB202407366D0 (en) * 2024-05-23 2024-07-10 Glycos Biomedical Ltd Preparation of medium molecular weight heparin

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136620A (en) 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
FR2614026B1 (fr) 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
EP0362810B1 (en) * 1988-10-07 1993-05-05 Hoechst Aktiengesellschaft Antimalarial compositions using quinidine, artemisinine and its derivatives
SE9002550D0 (sv) 1990-08-01 1990-08-01 Kabivitrum Ab Heparinfragment
SE9003181D0 (sv) * 1990-10-04 1990-10-04 Kabivitrum Ab Use of heparin fraction
US5250519A (en) * 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
US5280016A (en) * 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
JPH0532703A (ja) * 1991-07-26 1993-02-09 Terumo Corp 低分子量ヘパリン誘導体の製造法
WO1994008595A1 (en) 1992-10-13 1994-04-28 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5527785A (en) * 1993-05-14 1996-06-18 The Regents Of The University Of California Selectin receptor modulating compositions
EP0735050B1 (en) * 1995-03-31 2002-09-25 Hamilton Civic Hospitals Research Development, Inc. Compositions for inhibiting thrombogenesis
US5993810A (en) 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
US5767269A (en) 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
AU4572797A (en) 1996-10-15 1998-05-11 Toray Industries, Inc. Cervical canal maturing agent
GB9711443D0 (en) 1997-06-03 1997-07-30 Leo Pharm Prod Ltd Chemical suppositions
WO1999026984A1 (fr) * 1997-11-20 1999-06-03 Ikuo Yamashina Modification de l'heparine de faible masse moleculaire et remede contre l'ulcere de la peau
US6596705B1 (en) * 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin
US6498246B1 (en) 1998-02-26 2002-12-24 Seikagaku Corporation Glycosaminoglycan derivatives and processes for preparing same
US6028061A (en) * 1998-06-18 2000-02-22 Children's Medical Center Corp Angiogenesis inhibitors and use thereof
WO2000006608A1 (en) * 1998-07-31 2000-02-10 Seikagaku Corporation Novel glycosaminoglycan and drug compositions containing the same
CA2377734A1 (en) * 1999-06-30 2001-01-11 Hamilton Civic Hospitals Research Development, Inc. Heparin compositions that inhibit clot associated coagulation factors
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
IT1316986B1 (it) 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
DE60138115D1 (de) * 2000-09-12 2009-05-07 Massachusetts Inst Technology Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
SE521676C2 (sv) 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
EP1542704A1 (en) 2002-04-18 2005-06-22 Stephen H. Embury Method and composition for preventing pain in sickle cell patients
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
EP1582531A1 (en) * 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ATE516019T1 (de) * 2004-05-11 2011-07-15 Egalet Ltd Quellbare dosierform mit gellan-gummit
US20060040896A1 (en) 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
US7741311B2 (en) * 2005-01-03 2010-06-22 Shaker Mousa Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
US20080214480A1 (en) 2005-07-22 2008-09-04 Trf Pharma, Inc. Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae
ZA200801696B (en) * 2005-07-22 2009-08-26 Univ California Heparin compositions and selection inhibition
CN101495517B (zh) * 2006-05-25 2012-10-10 莫曼塔医药品有限公司 低分子量肝素及其用途
WO2009007224A1 (en) * 2007-07-10 2009-01-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Low molecular weight heparin derivatives having neuroprotective activity
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8592393B2 (en) * 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
ES2567079T3 (es) * 2007-11-02 2016-04-19 Momenta Pharmaceuticals, Inc. Composiciones de polisacáridos que no son anticoagulantes
WO2009073184A1 (en) 2007-12-03 2009-06-11 Florida State University Research Foundation, Inc. Compositions for inducing labor and associated methods
CA2719666C (en) * 2008-04-04 2016-08-16 Glenn Prestwich Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
AU2009273747A1 (en) * 2008-07-25 2010-01-28 Alphapharm Pty Ltd Atovaquone with a particle size diameter range (D90) of greater than 3 um to about 10 um
AU2010236222B2 (en) 2009-04-16 2015-10-15 Momenta Pharmaceuticals, Inc. Methods of assessing activity of a polysaccharide composition
AU2010268756A1 (en) * 2009-06-30 2012-01-19 The Walter And Eliza Hall Institute Of Medical Research Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
CN104144950B (zh) 2011-12-19 2017-09-05 迪乐方有限责任公司 含有重复的二糖单元的非抗凝的葡糖胺聚糖及其医药用途
HK1203370A1 (en) 2012-03-26 2015-10-30 迪乐方有限责任公司 Method for treatment of labor arrest
HK1203369A1 (en) 2012-03-26 2015-10-30 迪乐方有限责任公司 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Similar Documents

Publication Publication Date Title
JP2015500387A5 (https=)
SI2794667T1 (en) Low anticoagulant heparins
JP2015500388A5 (https=)
CA2397964A1 (en) Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
JP2009538386A5 (https=)
JP2005506326A5 (https=)
RU2010122324A (ru) Полисахаридные композиции, не обладающие антикоагулянтными свойствами
RU2014129816A (ru) Неантикоагулянтные гликозаминогликаны, содержащие повторяющиеся дисахаридные звенья, и их медицинское применение
JP2003523460A5 (https=)
CN1547477A (zh) 具有抗血管生成活性且没有抗凝作用的作为类肝素酶抑制剂的部分脱硫酸化糖胺聚糖衍生物
IL153922A (en) Heparin-derived polysaccharide mixtures, method of preparation and pharmaceutical preparations containing them
EA033936B1 (ru) Усовершенствованный способ получения сульфатированной ha высокой степени чистоты
JP4865552B2 (ja) ヘパリン−誘導オリゴ糖混合物、その製造およびその混合物を含有する医薬組成物
JPH10218902A5 (https=)
US20110178039A1 (en) Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
JP4897991B2 (ja) 超低分子量ヘパリン組成物
KR20200031059A (ko) 황산화 히알루론산 기반의 하이드로겔 및 이를 포함하는 약제학적 조성물
JP2015516415A5 (https=)
NZ537411A (en) Heparin-derived polysaccharide mixtures and preparation method
HK1200471B (en) Low anticoagulant heparins
HK1059273B (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same